# Food Effect and Mass Balance Study of XZP-3621 Tablets

> **NCT05034120** · PHASE1 · COMPLETED · sponsor: **Xuanzhu Biopharmaceutical Co., Ltd.** · enrollment: 34 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** XZP-3621
- **DRUG:** XZP-3621
- **DRUG:** XZP-3621
- **DRUG:** XZP-3621
- **DRUG:** XZP-3621
- **DRUG:** XZP-3621
- **DRUG:** XZP-3621

## Key facts

- **NCT ID:** NCT05034120
- **Lead sponsor:** Xuanzhu Biopharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-23
- **Primary completion:** 2022-03-30
- **Final completion:** 2022-03-30
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05034120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05034120, "Food Effect and Mass Balance Study of XZP-3621 Tablets". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05034120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*